Inventor · disambiguated record
David Wensbo
Also filed as: WENSBO DAVID
13 granted patents·21 pending applications·94 citations·filing 2001–2019
89Inventor score
Files withASTRAZENECA AB16NPS PHARMA INC6ASTRAZENECA AND NPS PHARMACEUT2GRAVENFORS YLVA2MINIDIS ALEXANDER2
Top patents by PatentIndex Score
34 records- 0193US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0285US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 0383US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 0482US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 0579US8163928B2Heteroaryl substituted benzothiazolesGRAVENFORS YLVA·Filed 2007·Granted Apr 24, 2012·7 cites·10 claims
- 0678US7772256B22-heteroaryl substituted benzothiophenes and benzofuranes 709ASTRAZENECA AB·Filed 2008·Granted Aug 10, 2010·4 cites·6 claims
- 0772US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 0868US7670591B2Heteroaryl substituted benzoxazolesASTRAZENECA AB·Filed 2007·Granted Mar 2, 2010·1 cites·31 claims
- 0967US8957215B2Heteroaryl substituted benzothiazolesGRAVENFORS YLVA·Filed 2012·Granted Feb 17, 2015·1 cites·29 claims
- 1062US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1162US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1262US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1362US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1457US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 1555US2010092385A1Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine DerivativesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1653US2007270469A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 1753US2007270468A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 1849US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 1949US2010098631A1Novel-2-Heteroaryl Substituted Indoles 695ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2048US2006019997A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2148US2007185178A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2248US2006063772A1New compoundsARORA JALAJ·Filed 2005·Application pending·0 cites
- 2348US2007197549A1Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2448US2007255061A15-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5ASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2547US2006025414A1Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2647US2004132726A1New compoundsASTRAZENECA AB AND NPS PHARMAC·Filed 2003·Application pending·0 cites
- 2747US2007185100A1Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2845US2004152699A1CompoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2003·Application pending·0 cites
- 2942US2005004130A1New metabotropic glutamate receptor compoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2004·Application pending·0 cites
- 3040US2007185095A1Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 3138US2004127576A1Estrogen receptor modulatorsFiled 2001·Application pending·0 cites
- 3234US11680054B2Bronchodilating hetero-linked amidesARCEDE PHARMA AB·Filed 2019·Granted Jun 20, 2023·0 cites·20 claims
- 3334US8318768B2Bronchodilating alpha, beta-unsaturated isoquinoline amidesDALENCE MARIA·Filed 2008·Granted Nov 27, 2012·0 cites·25 claims
- 3425US8415333B2Bronchodilating diazaheteroarylsJOHANSSON MARTIN·Filed 2010·Granted Apr 9, 2013·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when David Wensbo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →